Serotonin and Noradrenaline Reuptake Inhibitors (SNRI) updated on 07-01-2025

Minor congenital malformations

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S11684
R42939
Ankarfeldt a - Duloxetine (Controls unexposed, NOS), 2021 Minor malformations 1st trimester population based cohort retrospective unexposed (general population or NOS) excluded Adjustment: Yes Monotherapy: no or not specified 1.15 [0.89;1.49]
excluded (control group)
62/1,430   60,888/1,965,441 60,950 1,430
ref
S11685
R42955
Ankarfeldt a - Duloxetine (Controls unexposed, sick), 2021 Minor malformations 1st trimester population based cohort retrospective unexposed, sick Adjustment: Yes Monotherapy: no or not specified Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) 1.24 [0.89;1.73] 62/1,444   95/2,724 157 1,444
ref
S11774
R43317
Richardson - Venlafaxine, 2019 Minor congenital malformation (genetic conditions excluded) 1st trimester prospective cohort unexposed (general population or NOS) Adjustment: No Matched Monotherapy: no or not specified 0.55 [0.17;1.82] C 3/270   28/1,400 31 270
ref
Total 2 studies 1.02 [0.52;2.01] 188 1,714
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Ankarfeldt a - Duloxetine (Controls unexposed, sick), 2021Ankarfeldt a - Duloxetine, 2021 1 1.24[0.89; 1.73]1571,44476%ROB confusion: seriousROB selection: moderateROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: low Richardson - Venlafaxine, 2019Richardson - Venlafaxine, 2019 0.55[0.17; 1.82]3127024%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: moderateROB mesure: criticalROB reporting: moderate Total (2 studies) I2 = 39% 1.02[0.52; 2.01]1881,7140.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.02[0.52; 2.01]1881,71439%NAAnkarfeldt a - Duloxetine (Controls unexposed, sick), 2021 Richardson - Venlafaxine, 2019 2 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 0.55[0.17; 1.82]31270 -NARichardson - Venlafaxine, 2019 1 unexposed, sickunexposed, sick 1.24[0.89; 1.73]1571,444 -NAAnkarfeldt a - Duloxetine (Controls unexposed, sick), 2021 1 Tags Adjustment   - No  - No 0.55[0.17; 1.82]31270 -NARichardson - Venlafaxine, 2019 1   - Yes  - Yes 1.24[0.89; 1.73]1571,444 -NAAnkarfeldt a - Duloxetine (Controls unexposed, sick), 2021 1 MatchedMatched 0.55[0.17; 1.82]31270 -NARichardson - Venlafaxine, 2019 1 Monotherapy   - no or not specified  - no or not specified 1.02[0.52; 2.01]1881,71439%NAAnkarfeldt a - Duloxetine (Controls unexposed, sick), 2021 Richardson - Venlafaxine, 2019 2 Unexposed sick   - intermediate history of illness/tre ...  - intermediate history of illness/treatment (3-12 months before pregnancy) 1.24[0.89; 1.73]1571,444 -NAAnkarfeldt a - Duloxetine (Controls unexposed, sick), 2021 1 All studiesAll studies 1.02[0.52; 2.01]1881,71439%NAAnkarfeldt a - Duloxetine (Controls unexposed, sick), 2021 Richardson - Venlafaxine, 2019 20.25.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 11684

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.01[0.59; 1.75]60,9811,70028%NAAnkarfeldt a - Duloxetine (Controls unexposed, NOS), 2021 Richardson - Venlafaxine, 2019 2 unexposed, sick controlsunexposed, sick controls 1.24[0.89; 1.73]1571,444 -NAAnkarfeldt a - Duloxetine (Controls unexposed, sick), 2021 10.510.01.0